Skip to main content
Article
Enhancement of Immunity by a DNA Melanoma Vaccine against TRP2 with CCL21 as an Adjuvant
Molecular Therapy (2006)
  • Tomoki Yamano, Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
  • Yasufumi Kaneda, Osaka University
  • Sharon Huang, Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
  • Suzanne H. Hiramatsu, Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA
  • Dave S.B. Hoon
Publication Date
January 1, 2006
DOI
10.1016/j.ymthe.2005.05.018
Citation Information
Tomoki Yamano, Yasufumi Kaneda, Sharon Huang, Suzanne H. Hiramatsu, et al.. "Enhancement of Immunity by a DNA Melanoma Vaccine against TRP2 with CCL21 as an Adjuvant" Molecular Therapy Vol. 13 Iss. 1 (2006) p. 194 - 202
Available at: http://works.bepress.com/dave-hoon/244/